data exchange

presented by
Health Tech

Anti-Information Blocking Fines Are Coming Later This Summer — Here’s What You Need to Know

The OIG recently added some teeth to the anti-information blocking regulations laid out in the 21st Century Cures Act. The office finalized penalties, including fines of up to $1 million for health IT companies found blocking the electronic flow of health data. Interoperability expert Troy Bannister said that these fines are a good starting point for ensuring greater interoperability, but he isn’t too sure the OIG will be able to effectively enforce them.

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.